Immunological characteristics of bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases

Front Immunol. 2024 Oct 25:15:1408880. doi: 10.3389/fimmu.2024.1408880. eCollection 2024.

Abstract

Interstitial lung disease (ILD) is a serious complication of connective tissue diseases (CTDs). The heterogeneity of ILDs reflects differences in pathogenesis among diseases. This study aimed to clarify the characteristics of CTD-ILDs via a detailed analysis of the bronchoalveolar lavage fluid (BALF) and blood immune cells. BALF and blood samples were collected from 39 Japanese patients with newly diagnosed ILD: five patients with Sjögren's syndrome (SS), eight patients with dermatomyositis (DM), six patients with rheumatoid arthritis (RA), six patients with systemic sclerosis, four patients with anti-neutrophil cytoplasmic antibody-associated vasculitis, and 10 patients with idiopathic interstitial pneumonia. We performed single-cell RNA sequencing to analyze the gene expression profiles in these patients' immune cells. In patients with SS, B cells in the BALF were increased and genes associated with the innate and acquired immunity were enriched in both the BALF and blood. In contrast, patients with DM showed an upregulation of genes associated with viral infection in both the BALF and blood. In patients with RA, neutrophils in the BALF tended to increase, and their gene expression patterns changed towards inflammation. These disease-specific characteristics may help us understand the pathogenesis for each disease and discover potential biomarkers.

Keywords: connective tissue disease; genetics; interstitial lung disease; single-cell RNA sequencing; systemic autoimmune rheumatic disease.

MeSH terms

  • Adult
  • Aged
  • Biomarkers
  • Bronchoalveolar Lavage Fluid* / immunology
  • Connective Tissue Diseases* / immunology
  • Female
  • Humans
  • Lung Diseases, Interstitial* / immunology
  • Male
  • Middle Aged

Substances

  • Biomarkers

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by GSK Japan Research Grant (A-87), and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JP19K24000 and JP21K16304). The authors declare that this study received funding from Nippon Boehringer Ingelheim Co., Ltd. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.